Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31749 (
AKT
)
22,954
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Zinc finger protein 521
(
ZNF521
) plays an important role in the tumor development and process. However, its regulatory role in hepatocellular carcinoma (HCC) remains unclear. In this study, we demonstrated for the first time that
ZNF521
mRNA and protein was down-regulated in HCC tissues and cell lines. Down-regulated
ZNF521
expression was significantly associated with malignant prognostic features, including advanced TNM stage and large tumor size. For 5-year survival,
ZNF521
served as a potential prognostic marker of HCC patients. Moreover,
ZNF521
inhibited cell proliferation, colony formation and cell viability through Runx2 transcriptional inhibition and
AKT
phosphorylation pathway. Moreover, we demonstrated that
ZNF521
expression was regulated by miR-802. In HCC tissues. MiR-802 has an inverse correlation with
ZNF521
expression. In conclusion, we demonstrate for the first time that
ZNF521
is down-regulated in HCC tissues and inhibits HCC growth through Runx2 transcriptional inhibition and
AKT
inactivation, which was regulated by miR-802, suggesting the potential therapeutic value for HCC.
...
PMID:ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression. 3291 76